Ulrich Laufs to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Ulrich Laufs has written about Randomized Controlled Trials as Topic.
Connection Strength
0.013
-
Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials. Diabetes Metab. 2020 09; 46(4):280-287.
Score: 0.013
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.